Skip to main content icon/video/no-internet

Methadone maintenance treatment (MMT) has been the primary form of treatment for heroin addiction for many years and has been recognized as the most effective treatment for this condition by the Institute of Medicine and the National Institutes of Health. As a treatment for opioid dependence, MMT involves the daily administration of the oral opioid agonist methadone, a long-acting, orally administered drug, to replace the shorter acting heroin that is usually injected. As a maintenance medication, methadone has distinct advantages. When administered in adequate oral doses, a single dose lasts between 24 and 36 hours. Methadone is dispensed orally in different forms, which include tablets (also called diskettes), powder, and liquid. Most importantly, methadone relieves the persistent narcotic craving or hunger that is believed to be the major reason for relapse to heroin. MMT involves providing drug abusers with methadone in a clinical setting, a methadone maintenance treatment program (MMTP). In the United States alone, there are more than 1,200 MMTPs, with an estimated staff of 20,000 serving more than 220,000 patients annually. MMT is intended to do three things for patients who participate: (1) keep the patient from going into withdrawal, (2) keep the patient comfortable and free from craving street opioids, and (3) block the effects of street opioids.

The operations of a MMTP are regulated by federal and state regulations. MMTPs are staffed by physicians, physician assistants, nurses, social workers, addiction counselors, case managers, vocational counselors, HIV counselors, and administrative supervisors. The methadone dose is determined by the physician, who adjusts it according to the patient's need, withdrawal, and craving symptoms. Daily dispensing and observation of methadone, supervised urine drug screens, and other medical treatments (i.e., HIV/AIDS and hepatitis screening) are provided by nurses and physicians assistants. Clinical staff members provide individual and group counseling, case management, cognitive and behavioral treatments, and psychotherapy. The ability to provide all of these treatments in one location has made MMT the most effective treatment for opiate dependence to date.

Effectiveness

For over 30 years, methadone maintenance has been the most extensively researched form of maintenance treatment for opioid dependence in the United States. Methadone has been demonstrated repeatedly to be a safe and effective treatment with minimal side effects when used with appropriate safeguards and psychosocial services. Randomized trials have shown that methadone treatment, even with minimal counseling, is far superior to no treatment. Studies have shown that heroin users in MMT show marked reductions in illicit drug use and criminal activity and improvements in employment rates and psychological status.

Research has shown that program characteristics are critical factors in successful outcomes. The major factors in treatment retention are methadone dosage and length of time in treatment. Patients maintained on a daily dose of 60 milligrams (mg) or more had longer retention in treatment, less use of heroin and other drugs (including cocaine), and a lower incidence of HIV infection and AIDS. Other studies demonstrate the effectiveness of methadone was even greater for patients on a 70-mg dose and more pronounced for patients on 80 mg a day or more (further-reduced intravenous heroin). Studies also show that doses in excess of 100 mg a day are safe and necessary to eliminate opioid abuse and, in some cases, reduce abuse of alcohol and other drugs.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading